NIH Working on Ebola Vaccine
Human testing of a second investigational Ebola vaccine candidate is underway at the National Institutes of Health’s Clinical Center in Bethesda, according to the NIH website.
Researchers at the National Institute of Allergy and Infectious Diseases are conducting the early phase trial to evaluate the vaccine, called VSV-ZEBOV, for safety and its ability to generate an immune system response in healthy adults who are given two intramuscular doses, called a prime-boost strategy. The Walter Reed Army Institute of Research is simultaneously testing the vaccine candidate as a single dose at its Clinical Trials Center in Silver Spring, according to the NIH press release.
“The need for a vaccine to protect against Ebola infection is urgent,” said NIAID Director Anthony S. Fauci, M.D. “NIH welcomes the opportunity to collaborate with the U.S. Department of Defense to conduct human clinical tests of another promising — and hopefully, successful — Ebola vaccine candidate.”
Early human testing of another investigational Ebola vaccine co-developed by NIAID and GlaxoSmithKline began in early September. Initial data on safety and immunogenicity (the capacity to generate an immune response) from clinical trials of the NIAID/GSK Ebola vaccine are expected by the end of 2014.
The NIH Phase 1 clinical trial of the VSV-ZEBOV vaccine candidate will enroll 39 healthy adults aged 18 to 65 years. Participants will be randomly assigned to one of three groups with 13 participants each. In each group, 10 participants will receive the investigational VSV-ZEBOV vaccine; three will receive a placebo.
For more information about how you can volunteer to be part of the clinical trial click here.
The county’s health officer updated the Montgomery County Council Tuesday on the topics of Ebola, tuberculosis and school vaccinations. Dr. Ulder Tillman gives a public health briefing to the county council about twice a year. Of the 11,001 Montgomery County Public Schools’ sixth graders entering seventh grade in August, 7,098 still do not have the required Tdap (tetanus-diphtheria-acellular […]
UPDATED April 9, 5:44 p.m. The American healthcare worker admitted to the NIH Clinical Center on March 13 with the Ebola virus was discharged today in good condition after having been successfully treated at the NIH Clinical Center Special Clinical Studies Unit. According to NIH officials, the individual is no longer contagious to the community. No […]
Here are your five things to know today, April 8, in Montgomery County: 1. A Hate Crime: Gaithersburg police are looking for the vandal(s) who defaced a synagogue in the Lakelands community and city leaders are speaking out about the incident. 2. Getting Better: NIH officials have upgraded the condition of a patient with the Ebola […]
Here are your five things to know today, March 13, in Montgomery County. 1. The 41st annual Public Safety Awards ceremony takes place today at the Bethesda North Marriott. 2. A healthcare worker diagnosed with the Ebola virus is scheduled to be admitted to NIH today. 3. Meet the two MCPS students who are campaigning […]
In this MyMCMedia Extra video, Zalgen Labs’ co-founder Dr. Luis Branco said as the newly approved rapid diagnostic test for Ebola hits the market he will need to ramp up production at his startup company. Related:
In this MyMCMedia Extra video, Zalgen Labs’ co-founder Dr. Luis Branco said the approval of a rapid diagnostic test for Ebola is a gamechanger. Related:
In this MyMCMedia Extra video, Dr. Luis Branco said he plans to return to Eastern Sierra Leone sometime this year to continue work on the recently approved rapid diagnostic test for the Ebola virus. Despite progress, he said there are always more questions to answer. Related:
In this MyMCMedia Extra video, Zalgen Labs’ co-founder Dr. Luis Branco talks about his work on the rapid diagnostic test for Ebola late last year in Africa and what happened when he returned to the United States. The World Health Organization approved a rapid diagnostic test for Ebola last week. Related:
It’s called a gamechanger: a rapid diagnostic test for Ebola has recently been approved and a startup Germantown company, Zalgen Labs, played a part in the development of that test. MyMCMedia’s Sonya Burke reports. You can find more information about this development and the Viral Hemorrhagic Fever Consortium that made it happen on its website. […]
Susan Prince, development specialist for the Montgomery County Department of Economic Development, talks about Zalgen Labs and the impact that company’s success has on the life sciences industry here.